Business

Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit

Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit

articleNeurizon Therapeutics LimitedDecember 12, 20174/company/neurizon-therapeutics-limited/news/phase-ii-dog-lymphoma-trial-confirms-mpl-clinical-benefit
Phase II Dog Lymphoma Trial Confirms MPL Clinical Benefit

About this update from Neurizon Therapeutics Limited

[{"type":"text","content":"Neurizon Therapeutics Limited has released a press release. View Attachment","length":256,"tagName":"div"}]

More updates from Neurizon Therapeutics Limited